168 related articles for article (PubMed ID: 15619214)
1. Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis.
Shimizu C; Hasegawa T; Tani Y; Takahashi F; Takeuchi M; Watanabe T; Ando M; Katsumata N; Fujiwara Y
Hum Pathol; 2004 Dec; 35(12):1537-42. PubMed ID: 15619214
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neu overexpressing metastatic breast cancer.
Köstler WJ; Hudelist G; Rabitsch W; Czerwenka K; Müller R; Singer CF; Zielinski CC
J Cancer Res Clin Oncol; 2006 Jan; 132(1):9-18. PubMed ID: 16184380
[TBL] [Abstract][Full Text] [Related]
3. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients.
Heskamp S; Boerman OC; Molkenboer-Kuenen JD; Wauters CA; Strobbe LJ; Mandigers CM; Bult P; Oyen WJ; van der Graaf WT; van Laarhoven HW
PLoS One; 2015; 10(2):e0117745. PubMed ID: 25680198
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor receptor-1 (IGF-1R) expression in normal breast, proliferative breast lesions, and breast carcinoma.
Bhargava R; Beriwal S; McManus K; Dabbs DJ
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):218-25. PubMed ID: 21217522
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes.
Yerushalmi R; Gelmon KA; Leung S; Gao D; Cheang M; Pollak M; Turashvili G; Gilks BC; Kennecke H
Breast Cancer Res Treat; 2012 Feb; 132(1):131-42. PubMed ID: 21574055
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.
Kalinina T; Bockhorn M; Kaifi JT; Thieltges S; Güngör C; Effenberger KE; Strelow A; Reichelt U; Sauter G; Pantel K; Izbicki JR; Yekebas EF
Int J Cancer; 2010 Oct; 127(8):1931-40. PubMed ID: 20104520
[TBL] [Abstract][Full Text] [Related]
8. IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance.
Zhang X; Sun J; Wang H; Lou Y; Zhang Y; Sha H; Feng J; Han B
Tumour Biol; 2014 Jan; 35(1):739-45. PubMed ID: 23990442
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-1 receptor expression in thymic malignancies.
Girard N; Teruya-Feldstein J; Payabyab EC; Riely GJ; Rusch VW; Kris MG; Zakowski MF
J Thorac Oncol; 2010 Sep; 5(9):1439-46. PubMed ID: 20736806
[TBL] [Abstract][Full Text] [Related]
10. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
Kim YH; Sumiyoshi S; Hashimoto S; Masago K; Togashi Y; Sakamori Y; Okuda C; Mio T; Mishima M
Clin Lung Cancer; 2012 Sep; 13(5):385-90. PubMed ID: 22285568
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.
Valsecchi ME; McDonald M; Brody JR; Hyslop T; Freydin B; Yeo CJ; Solomides C; Peiper SC; Witkiewicz AK
Cancer; 2012 Jul; 118(14):3484-93. PubMed ID: 22086503
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy.
Gradishar WJ; Yardley DA; Layman R; Sparano JA; Chuang E; Northfelt DW; Schwartz GN; Youssoufian H; Tang S; Novosiadly R; Forest A; Nguyen TS; Cosaert J; Grebennik D; Haluska P
Clin Cancer Res; 2016 Jan; 22(2):301-9. PubMed ID: 26324738
[TBL] [Abstract][Full Text] [Related]
13. IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer.
Peters G; Gongoll S; Langner C; Mengel M; Piso P; Klempnauer J; Rüschoff J; Kreipe H; von Wasielewski R
Virchows Arch; 2003 Aug; 443(2):139-45. PubMed ID: 12845531
[TBL] [Abstract][Full Text] [Related]
14. Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer.
Kim JS; Kim ES; Liu D; Lee JJ; Behrens C; Lippman SM; Hong WK; Wistuba II; Lee E; Lee HY
Oncotarget; 2015 Jun; 6(18):16746-56. PubMed ID: 25944691
[TBL] [Abstract][Full Text] [Related]
15. Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma.
Xia M; Overman MJ; Rashid A; Chatterjee D; Wang H; Katz MH; Fleming JB; Lee JE; Varadhachary GR; Wolff RA; Wang H
Hum Pathol; 2015 Sep; 46(9):1315-22. PubMed ID: 26165226
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.
Asmane I; Watkin E; Alberti L; Duc A; Marec-Berard P; Ray-Coquard I; Cassier P; Decouvelaere AV; Ranchère D; Kurtz JE; Bergerat JP; Blay JY
Eur J Cancer; 2012 Nov; 48(16):3027-35. PubMed ID: 22682017
[TBL] [Abstract][Full Text] [Related]
17. Impact of epidermal growth factor receptor, mesenchymal-epithelial transition factor, and insulin-like growth factor receptor 1 expression on survival of patients with oral and oropharyngeal cancer.
Perisanidis C; Wrba F; Brandstetter A; Kornek G; Mitchell D; Seemann R; Selzer E; Ewers R; Filipits M
Br J Oral Maxillofac Surg; 2013 Apr; 51(3):234-40. PubMed ID: 22889668
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab.
Christodoulou C; Oikonomopoulos G; Koliou GA; Kostopoulos I; Kotoula V; Bobos M; Pentheroudakis G; Lazaridis G; Skondra M; Chrisafi S; Koutras A; Bafaloukos D; Razis E; Papadopoulou K; Papakostas P; Kalofonos HP; Pectasides D; Skarlos P; Kalogeras KT; Fountzilas G
Cancer Genomics Proteomics; 2018; 15(6):461-471. PubMed ID: 30343280
[TBL] [Abstract][Full Text] [Related]
19. Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.
Matsubara J; Yamada Y; Hirashima Y; Takahari D; Okita NT; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
Clin Cancer Res; 2008 May; 14(10):3022-9. PubMed ID: 18483367
[TBL] [Abstract][Full Text] [Related]
20. Value of expression of insulin-like growth factor-1 receptor in gastric adenocarcinomas and normal gastric tissues.
Topalak Ö; Uğur Kantar F; Ulukuş Ç; Küpelioğlu A
Turk J Gastroenterol; 2014 Apr; 25(2):141-6. PubMed ID: 25003672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]